Tumor stiffness and stiffness change using 3D MR elastography are markers of tumor lymphocyte infiltration and immunotherapy response in HCC.
Paul Kennedy1, Muhammed Shareef1, Octavia Bane1, Guillermo Carbonell1, Elizabeth Miller2, Israel Lowy2, Stephen Ward1, M. Isabel Fiel1, Miriam Merad1, Thomas Marron1, and Bachir Taouli1
1Icahn School of Medicine at Mount Sinai, New York, NY, United States, 2Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States
Tumor
stiffness measured with 3D MRE correlates with grade of tumor infiltrating
lymphocytes, and tumor stiffness changes are associated with degree of tumor
necrosis following immunotherapy.
Figure 1: Example pre- and post-immunotherapy images
from an 83 yr old female with hepatitis B. A 7cm hepatocellular carcinoma is
seen in the right lobe (white outline). A moderate decrease in tumor stiffness
(TS) is noted post immunotherapy however liver stiffness (LS) remains
unchanged. At resection the tumor was 100% necrotic.
Figure 2:
Boxplot showing elevated baseline stiffness in tumors with high density of
tumor infiltrating lymphocytes at resection.